StonvexLoading…
StonvexStonvexStonvexCore line items from AIRO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $90.91M | $42.63M | $36.34M | $86.94M |
Operating Income | $-28.77M | $-34.75M | $-22.77M | $-17.43M |
Net Income | $-4.10M | $-4.06M | $3.90M | $-38.69M |
EPS (Diluted) | $-0.17 | $-0.19 | $0.20 | $-2.36 |
Total Assets | $774.14M | $774.58M | $747.85M | $701.00M |
Total Liabilities | $34.95M | $35.03M | $68.29M | $152.27M |
Cash & Equivalents | $74.55M | $83.68M | $40.54M | $20.91M |
Free Cash Flow OCF − CapEx | $-35.51M | $-38.53M | $-31.82M | $20.70M |
Shares Outstanding | 31.38M | 31.30M | 27.03M | 16.39M |